Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
14
Number of overlapping holdings
16.5%
% of SBIO's 90 holdings also in IBRN
33.3%
% of IBRN's 60 holdings also in SBIO
Overlap by Weight
Sector Drift (SBIO minus IBRN)
Overlapping Holdings
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in SBIO |
Weight in IBRN |
Overlap | |
|---|---|---|---|---|
 |
ALKERMES PLC | 4.5% | 4.1% | 4.1% |
 |
PTC THERAPEUTICS INC | 3.6% | 4.4% | 3.6% |
|
ACADIA PHARMACEUTICALS INC | 2.4% | 4.1% | 2.4% |
|
DENALI THERAPEUTICS INC. | 1.9% | 3.7% | 1.9% |
|
EDGEWISE THERAPEUTICS, INC. | 1.9% | 3.3% | 1.9% |
Position Highlights (Non-Overlapping Exposures)
SBIO Overweight Relative to IBRN
|
AXSOME THERAPEUTICS, INC. | 4.5% |
 |
ZAI LAB LTD. UNSPONSORED ADR | 3.3% |
|
AVIDITY BIOSCIENCES INC | 3.2% |
|
RHYTHM PHARMACEUTICALS, INC. | 3.0% |
|
AKERO THERAPEUTICS, INC. | 2.9% |
|
CRINETICS PHARMACEUTICALS INC | 2.7% |
 |
MERUS N.V. | 2.7% |
|
PROTAGONIST THERAPEUTICS, INC. | 2.6% |
 |
MOONLAKE IMMUNOTHERAPEUTICS CLASS A | 2.2% |
|
AMICUS THERAPEUTICS INC | 2.2% |
SBIO Underweight Relative to IBRN
|
CATALYST PHARMACEUTICAL PART | -4.7% |
|
INTRA-CELLULAR THERAPIES INC | -4.2% |
|
NEUROCRINE BIOSCIENCES INC | -4.2% |
 |
ARGENX SE ADR | -4.2% |
 |
SK BIOPHARMACEUTICALS CO., LTD. | -3.9% |
|
BIOGEN IDEC INC | -3.9% |
|
SCHOLAR ROCK HOLDING CORP. | -3.9% |
|
SUPERNUS PHARMACEUTICALS INC | -3.7% |
|
INTEGRA LIFESCIENCES HOLDING | -3.1% |
|
SAREPTA THERAPEUTICS INC | -2.9% |